Research - Ness Ziona, Center District, Israel
On a mission to extend the reach of biological therapeutics to the brain to tackle CNS diseases head-on, Nanocarry is pioneering a BioConvergence approach that enables biologics to access the brain, overcoming the Blood-Brain Barrier (BBB). Our proprietary technology platform, AxS, redefines biology's frontiers by creating biologics powered by nanoparticle properties, which are transported safely and effectively to the brain.
Outlook
Wix
Google Font API
Mobile Friendly
GoDaddy Hosting